Latigo Stock May Profit From Vertex Market
Latigo Biotherapeutics (LTGO) could see significant gains as Vertex's market groundwork supports its onzotrigine trials.
Seekingalpha · 1m
Glaukos Stock: Second J-Code Rewrites Risk Math
Glaukos' second J-code drug launch reshapes risk math for investors.
Seekingalpha · 1m